Equity ETFs Pfizer Acquires Anacor, Reviving M&A Bets in Biotech Sector, ETFs By Max ChenMay 16, 2016
Equity ETFs Healthcare ETFs Perk up as U.S. Economy Moves to Late-Cycle Phase By Tom LydonApril 18, 2016
Equity ETFs Silver Lining for Biotechnology ETFs After Pfizer Calls off Allergan Deal By Max ChenApril 6, 2016
Equity ETFs Healthcare Sector’s Malaise Creates Buying Opportunity for ETF Investors By Tom LydonMarch 22, 2016
